NCT04377334 Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS) Status UNKNOWN Phase PHASE2
NCT04377308 Fluoxetine to Reduce Intubation and Death After COVID19 Infection Status COMPLETED Phase PHASE4
NCT04376944 Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation Status UNKNOWN Phase N/A
NCT04376905 Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) Status COMPLETED Phase N/A
NCT04376879 Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) Status COMPLETED Phase N/A
NCT04376853 CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch Status COMPLETED Phase N/A
NCT04376814 Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 Status COMPLETED Phase NA
NCT04376788 Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 Status UNKNOWN Phase PHASE2
NCT04376398 Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals Status COMPLETED Phase N/A
NCT04375046 Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2 Status UNKNOWN Phase PHASE1
NCT04374695 Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19 Status UNKNOWN Phase N/A
NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic Status COMPLETED Phase N/A